G-CSF in the Treatment of Toxic Epidermal Necrolysis
NCT02739295
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Stevens - Johnson Syndrome
Interventions
DRUG:
recombinant granulocyte - colony stimulating factor
DRUG:
NaCl 0.9%
Sponsor
University of Liege